SBUR, EAU, ASCO and ESMO. Dr Schalken was co-founder and CSO of NovioGendix BV, a biomarker company recently acquired by MDxHealth SA and Oncodrone BV, a biopharmaceutical company. Dr Schalken is ...
Results that may be inaccessible to you are currently showing.